scholarly journals Comparison of the real‐world effectiveness of vertical versus lateral functional hemispherotomy techniques for pediatric drug‐resistant epilepsy: A post hoc analysis of the HOPS study

Epilepsia ◽  
2021 ◽  
Author(s):  
Aria Fallah ◽  
Evan Lewis ◽  
George M. Ibrahim ◽  
Olivia Kola ◽  
Chi‐Hong Tseng ◽  
...  
Keyword(s):  
Real World ◽  
Drug Resistant ◽  
Pediatric Drug ◽  
The Real ◽  
Post Hoc Analysis ◽  
Drug Resistant Epilepsy ◽  
Post Hoc

The role of targeted gene panel in pediatric drug-resistant epilepsy

2020 ◽  
Vol 106 ◽  
pp. 107003
Author(s):  
Chang-Chun Wu ◽  
Meng-Han Tsai ◽  
Yen-Ju Chu ◽  
Wen-Chin Weng ◽  
Pi-Chuan Fan ◽  
...  
Keyword(s):  
Gene Panel ◽  
Drug Resistant ◽  
Pediatric Drug ◽  
Drug Resistant Epilepsy

scholarly journals Novel Neurotechnological Interventions for Pediatric Drug-Resistant Epilepsy: Physician Perspectives

2020 ◽  
pp. 088307382096693
Author(s):  
Patrick J. McDonald ◽  
Viorica Hrincu ◽  
Mary B. Connolly ◽  
Mark J. Harrison ◽  
George M. Ibrahim ◽  
...  
Keyword(s):  
Decision Making ◽  
Best Practice ◽  
Clinical Decision Making ◽  
Qualitative Content Analysis ◽  
Scientific Evidence ◽  
Clinical Decision ◽  
Drug Resistant ◽  
Ethical Considerations ◽  
Pediatric Drug ◽  
Drug Resistant Epilepsy

This qualitative study investigated factors that guide physicians’ choices for minimally invasive and neuromodulatory interventions as alternatives to conventional surgery or medical management for pediatric drug-resistant epilepsy. North American physicians were recruited to one of 4 focus groups at national conferences. Discussions were analyzed using qualitative content analysis. A pragmatic neuroethics framework was applied to interpret results. Discussions revealed 2 major thematic branches: (1) clinical decision making and (2) ethical considerations. Under clinical decision making, physicians emphasized scientific evidence and patient candidacy when assessing neurotechnologies for patients. Ongoing seizures without intervention was important for safety and neurodevelopment. Under ethical considerations, resource allocation, among other financial considerations for technology adoption, were considerable sources of pressure on decision making. Access to neurotechnology was a salient theme differentiating Canadian and American contexts. When assessing novel neurotechnological interventions for pediatric drug-resistant epilepsy, physicians balance clinical and ethical factors to guide decision making and best practice.

scholarly journals Responsive neurostimulation for treatment of pediatric drug-resistant epilepsy

2018 ◽  
Vol 10 ◽  
pp. 21-24 ◽  
Author(s):  
Nilika S. Singhal ◽  
Adam L. Numis ◽  
Morgan B. Lee ◽  
Edward F. Chang ◽  
Joseph E. Sullivan ◽  
...  
Keyword(s):  
Drug Resistant ◽  
Pediatric Drug ◽  
Drug Resistant Epilepsy
Sign in / Sign up

Export Citation Format

Share Document